Clinical Evaluation of the Bioavailability of Zinc-enriched Yeast and Zinc Gluconate in Healthy Volunteers

Abstract

Zinc (Zn)-enriched yeast and gluconate are considered two of the more biologically available supplements. However, there have been few reports comparing the bioavailability of these supplements. The objective of this study was to demonstrate whether Zn was absorbed better by healthy male volunteers when given supplements where the mineral is found organically bound in yeast or as a salt gluconate form. The trial used a randomized, two-way crossover design. Urine, blood, and fecal samples were collected and analyzed over a 48-h period after a single dose of supplement. The net Zn balance and the relative bioavailability were calculated. No differences were observed in urine excretion of the two supplements. Zinc gluconate gave higher Zn concentrations in the blood in the first 6 h but also showed greater losses in the feces. Zinc yeast also increased in blood with time but showed significantly less loss in the feces. Thus, the net Zn balance after 48 h for Zn yeast was 9.46 but for Zn gluconate it was −2.00, indicating that Zn gluconate supplementation contributed to a net loss of Zn. It was concluded that organic Zn yeast supplements are more biologically available than Zn gluconate salts.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. 1.

    Maret W, Sandstead HH (2006) Zinc requirements and the risks and benefits of zinc supplementation. J Trace Elem Med Biol 20:3–18

    PubMed  Article  CAS  Google Scholar 

  2. 2.

    Cuevas LE, Koyanagi A (2005) Zinc and infection: a review. Ann Trop Paediatr 25:149–160

    PubMed  Article  Google Scholar 

  3. 3.

    Shah D, Sachdev HP (2006) Zinc deficiency in pregnancy and fetal outcome. Nutr Rev 64:15–30

    PubMed  Article  Google Scholar 

  4. 4.

    Hughes S, Samman S (2006) The effect of zinc supplementation in humans on plasma lipids, antioxidant status and thrombogenesis. J Am Coll Nutr 24:285–291

    Google Scholar 

  5. 5.

    Beletate V, El Dib R, Atallah A (2007) Zinc supplementation for the prevention of type 2 diabetes mellitus. Cochrane Database Syst Rev 24:CD005525

    Google Scholar 

  6. 6.

    Salgueiro MJ, Zubillaga MB, Lysionek AE, Sarabia MI, Caro RA, De Paoli T, Hager A, Ettlin E, Weill R, Boccio JR (2000) Bioavailability, biodistribution, and toxicity of BioZn-AAS; a new zinc source, comparative studies in rats. Nutrition 16:7623–766

    Google Scholar 

  7. 7.

    Neathery MW, Lassiter JW, Miller WJ, Gentry RP (1975) Absorption, excretion and tissue distribution of natural organic and inorganic zinc-65 in the rat. Proc Soc Exp Biol Med 149:1–4

    PubMed  CAS  Google Scholar 

  8. 8.

    Vinson JA, Tompkins TA, Agbor GA (2007) Comparative bioavailability of mineral enriched gluconates and yeasts in rat liver following depletion–repletion feeding. Biol Trace Elem Res (in press)

  9. 9.

    Vinson JA, Bose P, Lemoine L, Hsiao KH (1989) Comparative human bioavailability of zinc. In: Southgate D, Johnson I, Fenwick GR (eds) Nutrient availability: chemical and biological aspects. Royal Society of Chemistry Publications, Cambridge, England, pp 125–127

    Google Scholar 

  10. 10.

    Fischer PWF, Giroux A, L’Abbe MR (1984) Effect of zinc supplementation on copper status in adult man. Am J Clin Nutr 40:743–746

    PubMed  CAS  Google Scholar 

  11. 11.

    Yadrick MK, Kennery MA, Winterfeldt EA (1989) Iron, copper, and zinc status: response to supplementation with zinc and iron in adult females. Am J Clin Nutr 49:145–150

    PubMed  CAS  Google Scholar 

  12. 12.

    Spencer H, Kramer L, Osis D (1982) Zinc balances in humans. In: Prasad AS (ed) Clinical, biochemical and nutritional aspects of trace elements. Alan R. Liss, New York, NY, pp 103–115

    Google Scholar 

  13. 13.

    Camara F, Amaro MA (2003) Nutritional aspect of zinc availability. Int J Food Sci Nutr 54:143–151

    PubMed  Article  CAS  Google Scholar 

Download references

Acknowledgements

The authors wish to gratefully acknowledge the technical support staff from the Medical Corporation LTA (Souseikai Osaki Clinic); B. M. L. Association; and Japan Food Research Laboratories and Sogo Clinical Pharmacology Co., Ltd. In addition, they wish to acknowledge the financial support of Lallemand Inc. (Montreal, Canada) and Space-H Enterprise Ltd. (Tokyo, Japan).

Author information

Affiliations

Authors

Corresponding author

Correspondence to Thomas A. Tompkins.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Tompkins, T.A., Renard, N.E. & Kiuchi, A. Clinical Evaluation of the Bioavailability of Zinc-enriched Yeast and Zinc Gluconate in Healthy Volunteers. Biol Trace Elem Res 120, 28–35 (2007). https://doi.org/10.1007/s12011-007-0072-2

Download citation

Keywords

  • Zinc gluconate
  • Zinc-enriched yeast
  • Bioavailability
  • Zinc absorption